MediciNova Inc (MNOV) income statement
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.33−0.01 (-0.75%)
Close on Nov 18, 2026Market cap $65.46MP/E –Yield –
MediciNova Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -1287.4%
- Net margin
- -1168.2%
- Return on equity, FY2025
- -25.5%
Financial strength
- Current ratio
- 8.75
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 858.3%
Valuation
- P/E ratio
- –
- Price to sales
- 71.12
- Price to book
- 1.76
- Dividend yield
- –
See a number that looks wrong?